Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for psychiatric symptoms in vascular dementia
RBR-686kmpzPhase 3Completed
- Sponsor
- Faculdade de Medicina de Ribeirão Preto
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in vascular dementia comparing Cannabidiol with Placebo (2 arms). Started Aug 2021; status: completed.
02
Drugs
cannabidiol
03
Conditions
vascular dementia
Beyond the preview
Go deeper on RBR-686kmpz.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-686kmpz.